142 related articles for article (PubMed ID: 35430345)
1. A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression.
Xu T; Jin T; Lu X; Pan Z; Tan Z; Zheng C; Liu Y; Hu X; Ba L; Ren H; Chen J; Zhu C; Ge M; Huang P
Cell Signal; 2022 Jul; 95():110332. PubMed ID: 35430345
[TBL] [Abstract][Full Text] [Related]
2. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
[TBL] [Abstract][Full Text] [Related]
3. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma.
Xu T; Zhu C; Chen J; Song F; Ren X; Wang S; Yi X; Zhang Y; Zhang W; Hu Q; Qin H; Liu Y; Zhang S; Tan Z; Pan Z; Huang P; Ge M
J Exp Clin Cancer Res; 2023 Jul; 42(1):182. PubMed ID: 37501099
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression.
Ma Y; Cang S; Li G; Su Y; Zhang H; Wang L; Yang J; Shi X; Qin G; Yuan H
J Cell Physiol; 2019 Dec; 234(12):22260-22271. PubMed ID: 31081124
[TBL] [Abstract][Full Text] [Related]
5. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma.
Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
[TBL] [Abstract][Full Text] [Related]
6. Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.
Weinberger P; Ponny SR; Xu H; Bai S; Smallridge R; Copland J; Sharma A
Thyroid; 2017 Feb; 27(2):236-252. PubMed ID: 27796151
[TBL] [Abstract][Full Text] [Related]
7. The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study.
Pan Z; Li L; Qian Y; Ge X; Hu X; Zhang Y; Ge M; Huang P
Cancer Biol Ther; 2020 Sep; 21(9):853-862. PubMed ID: 32887540
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
Li L; Zhu M; Huang H; Wu J; Meng D
Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
[TBL] [Abstract][Full Text] [Related]
9. TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.
Li HN; Du YY; Xu T; Zhang R; Wang G; Lv ZT; Li XR
Curr Med Sci; 2020 Dec; 40(6):1137-1147. PubMed ID: 33428142
[TBL] [Abstract][Full Text] [Related]
10. Diallyl trisulphide, a H
Zhang L; Xu S; Cheng X; Zheng J; Wang Y; Wu J; Wang X; Wu L; Yu H; Bao J
Phytother Res; 2021 Jun; 35(6):3428-3443. PubMed ID: 33751676
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis.
Liu G; Wu K; Sheng Y
Oncol Rep; 2016 Nov; 36(5):3005-3013. PubMed ID: 27599582
[TBL] [Abstract][Full Text] [Related]
13. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation.
Wang Y; Hou Z; Li D
Mol Med Rep; 2018 Sep; 18(3):3068-3076. PubMed ID: 30015867
[TBL] [Abstract][Full Text] [Related]
15. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
[TBL] [Abstract][Full Text] [Related]
16. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
[TBL] [Abstract][Full Text] [Related]
17. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
[TBL] [Abstract][Full Text] [Related]
18. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression.
Zhu C; Ke S; Li Y; Zhang W; Che Y; Zhang R; Huang P; Xu T
Heliyon; 2024 Mar; 10(5):e27150. PubMed ID: 38449652
[TBL] [Abstract][Full Text] [Related]
19. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.
Pan Z; Xu T; Bao L; Hu X; Jin T; Chen J; Chen J; Qian Y; Lu X; Li L; Zheng G; Zhang Y; Zou X; Song F; Zheng C; Jiang L; Wang J; Tan Z; Huang P; Ge M
Mol Cancer; 2022 Oct; 21(1):190. PubMed ID: 36192735
[TBL] [Abstract][Full Text] [Related]
20. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
Zhang W; Ji W; Zhao X
BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
